Yes Q1. will do just fine
Another question relating to Lachlan's incentives
Short Term Incentive: 30% Base Salary (maximum) pa subject to
achieving a range of KPI’s determined by the PET Board.
Long Term Incentive:
1,500,000 Performance Options
Exercise Price - $1.25 per option (convert into one share)
Vesting Date – 31 December 2021
Expiry Date – 31 December 2022
Vesting Conditions – PET Sales for FY2020 and FY2021 > $120 million
Due to COVID19, was anything written into this agreement with Lachlan or is there room for changes to his incentives because of natural disasters, sky falling in etc etc
- Forums
- ASX - By Stock
- PET
- Questions for the AGM
Questions for the AGM, page-4
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PET (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online